TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

F Stephen Hodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.